Search results for "Sclerosis"

showing 10 items of 1583 documents

Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresis.

2018

INTRODUCTION Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with monoclonal antibodies has complemented the armamentarium of lipid-lowering therapy (LLT) before the final step of commencing chronic lipoprotein apheresis (LA). Data are scarce on patients who, after escalation of LLT with PCSK9 antibodies, have commenced chronic LA or PCSK9 antibody treatment during ongoing long-term LA. PATIENTS AND METHODS In this study, a cohort of 110 patients with established atherosclerotic cardiovascular disease (ASCVD) due to hypercholesterolemia or concomitant lipoprotein(a)-hyperlipoproteinemia, who received PCSK9 antibodies for the first time during routine care, were consecutivel…

Malemedicine.medical_specialtymedicine.drug_classLipoproteinsHypercholesterolemia030204 cardiovascular system & hematologyMonoclonal antibodyGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansEnzyme InhibitorsAdverse effectbiologybusiness.industryPCSK9PCSK9 InhibitorsAntibodies MonoclonalHematologyGeneral MedicineLipoprotein(a)Cholesterol LDLMiddle AgedAtherosclerosisCombined Modality TherapyLipidsDiscontinuationConcomitantCohortbiology.proteinBlood Component RemovalFemaleAntibodyProprotein Convertase 9business030215 immunologyLipoprotein(a)Journal of clinical apheresis
researchProduct

Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention

2007

The aim of our study was to evaluate, in patients with proven coronary artery disease (CAD) and treated with elective percutaneous coronary intervention (PCI), whether the coexistence of asymptomatic carotid and femoral atherosclerotic lesions would provide prognostic information in terms of occurrence of restenosis.We studied 104 patients with CAD (M/F=77/27), mean age 60.5+/-9 years. All patients were treated with elective PCI. After PCI the suspicion of restenosis was confirmed by coronary angiography. All patients underwent ultrasound duplex scan of carotid and femoral-popliteal-tibial axis to detect atherosclerotic lesions. According to ultrasound results, patients were classified as n…

Malemedicine.medical_specialtymedicine.medical_treatmentBalloonAsymptomaticPeripheral atherosclerosispercutaneous coronary interventionCoronary RestenosisCoronary artery diseaseRestenosisInternal medicineAngioplastymedicineHumanscardiovascular diseasesAngioplasty Balloon CoronaryAgedPeripheral Vascular Diseasesbusiness.industryPercutaneous coronary interventionGeneral MedicineMiddle AgedAtherosclerosisPrognosismedicine.diseasePeripheralConventional PCICardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCoronary Artery Disease
researchProduct

CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins.

2007

Abstract Background CD14 receptor is a mediator of the inflammatory response to bacterial products. A functional polymorphism in the promoter of the CD14 gene (CD14 C-260T) was associated with coronary heart disease and atherosclerosis albeit with conflicting data. Methods To better clarify the role of CD14 in atherosclerosis, we typed CD14 C-260T polymorphism in old Italian (Central of Italy) atherosclerotic patients with carotid stenosis related to lipid assessment, inflammation (soluble CD14, IL-6 serum levels) and IL-6, TNF-α, IL-10, Metallothioneins (MT) gene expressions in carotid plaques. Results There was an increased frequency of TT homozygotes in patients when compared to controls…

Malemedicine.medical_specialtymedicine.medical_treatmentCD14Lipopolysaccharide ReceptorsInflammationchemistry.chemical_compoundInternal medicineGenotypemedicineHumansCD14 SNP atherosclerosis aging associated disease cytokines productionSettore MED/05 - Patologia ClinicaCarotid StenosisRNA MessengerAgedAged 80 and overPolymorphism GeneticTriglycerideCholesterolbusiness.industryOdds ratioAtherosclerosismedicine.diseaseCholesterolEndocrinologyCytokineAtheromaItalychemistryCase-Control StudiesImmunologyCytokinesFemaleMetallothioneinmedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Evolution of otosclerosis to cochlear implantation.

2011

Abstract Introduction Otosclerosis is an osteodystrophy of the labyrinthine capsule producing conductive hearing loss. If the process invades the cochlea, a sensorineural hearing loss usually takes place. The cochlear implant is a good alternative in these patients. Objective To ascertain the behaviour of cochlear implantation (CI) in otosclerosis. Material and methods We reviewed a database of 250 patients who underwent CI, performing a retrospective study of 13 patients with clinical, audiological and/or imaging findings of bilateral otosclerosis. The 26 ears were studied as to their natural history, previous surgeries, evolution to profound hearing loss, computed tomography (CT) images, …

Malemedicine.medical_specialtymedicine.medical_treatmentHearing Loss SensorineuralHearing Loss ConductiveDentistryStapes SurgeryHearing Loss BilateralTinnitusCochlear implantotorhinolaryngologic diseasesmedicineHumansOsteodystrophyAgedRetrospective Studiesbusiness.industryImplant failureRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseFacial nerveSurgeryConductive hearing lossFacial NerveCochlear ImplantsOtosclerosisTreatment OutcomeDisease ProgressionOtosclerosisSensorineural hearing lossFemalebusinessTomography X-Ray ComputedActa otorrinolaringologica espanola
researchProduct

Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis

2016

OBJECTIVE: To describe the clinical characteristics and evolution of our series of medication-related osteonecrosis of the jaws (MRONJ) associated with denosumab in osteoporotic patients. MATERIAL AND METHODS: We present 10 new cases of MRONJ in patients receiving denosumab for osteoporosis. We describe the mean doses of denosumab, previous bisphosphonate intake, and the clinical characteristics associated with the osteonecrosis, such as local contributing factors, symptoms, and evolution after treatment. RESULTS: The mean number of denosumab doses was 3.4 2.2. In 90% of patients, there was a prior history of oral bisphosphonate intake, with a mean duration of 46.78 25.11 months. The most c…

Malemedicine.medical_specialtymedicine.medical_treatmentOsteoporosisDentistryOdontología03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansStage (cooking)General DentistryAgedSclerosisMedicamentoBisphosphonate-associated osteonecrosis of the jawBone Density Conservation AgentsDiphosphonatesbusiness.industry030206 dentistryMiddle AgedBisphosphonatemedicine.diseaseBone Density Conservation AgentsDenosumabOtorhinolaryngologyDental extraction030220 oncology & carcinogenesisOsteoporosisBisphosphonate-Associated Osteonecrosis of the JawFemaleDenosumabTomography X-Ray ComputedOsteonecrosis of the jawbusinessmedicine.drugOral Diseases
researchProduct

Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance charac…

2007

For many years dextran sulfate adsorption (DSA) treatment of separated plasma has been an established technology for low-density lipoprotein (LDL)-elimination. Recently a system for the treatment of whole blood based on DSA was introduced into clinical practice. To further characterize DSA treatment of whole blood, the performance characteristics of both DSA modalities were compared at two investigational sites with two alternative LDL apheresis systems being already in routine clinical use. In prospective cross-over design, DSA whole blood treatment was compared with a whole blood polyacrylate LDL adsorption system (DALI) in one study group. DSA for plasma treatment was compared with Lipid…

Malemedicine.medical_specialtymedicine.medical_treatmentUrologyAcrylic ResinsFibrinogenchemistry.chemical_compoundmedicineHumansWhole bloodbusiness.industryCholesterolDextran SulfateBlood Component RemovalFibrinogenHematologyGeneral MedicineCholesterol LDLHemoperfusionAtherosclerosisSurgerybody regionsApheresischemistryLDL apheresisBlood Component RemovalFemalebusinessFiltrationmedicine.drugLipoproteinJournal of clinical apheresis
researchProduct

Noninvasive respiratory muscle aids during PEG placement in ALS patients with severe ventilatory impairment.

2010

Abstract Although no clear recommendations are given about when percutaneous endoscopic gastrostomy (PEG) should be placed in amyotrophic lateral sclerosis (ALS) patients, some experts underline the risk of respiratory complications when patients had severe ventilatory muscle impairment (SVMI). Aim To evaluate the efficacy of noninvasive ventilation (NIV) and mechanically assisted cough (MAC) to avoid respiratory complications related to PEG placement in ALS patients with SVMI. Material and methods Prospective study including ALS patients who had chosen to have PEG placement timed by swallowing dysfunction with the aid of NIV and MAC if needed. PEG was carried out under volume-cycled NIV th…

Malemedicine.medical_specialtymedicine.medical_treatmentVital CapacityBody Mass IndexFEV1/FVC ratioTracheotomyTracheostomySwallowingPercutaneous endoscopic gastrostomyGastroscopyRespiratory muscleMedicineHumansProspective StudiesAgedGastrostomybusiness.industryRespiratory diseaseAmyotrophic Lateral SclerosisMiddle Agedmedicine.diseaseRespiration DisordersGastrostomyRespiratory MusclesSurgeryRespiratory Function TestsNeurologyRespiratory failureCoughAnesthesiaFemaleNeurology (clinical)businessJournal of the neurological sciences
researchProduct

Haemodynamic predictors of a penetrating atherosclerotic ulcer rupture using fluid-structure interaction analysis

2013

We present preliminary data on the flow-induced haemodynamic and structural loads exerted on a penetrating atherosclerotic aortic ulcer (PAU). Specifically, one-way fluid-structure interaction analysis was performed on the aortic model reconstructed from a 66-year-old male patient with a PAU that evolved into an intramural haematoma and rupture of the thoracic aorta. The results show that elevated blood pressure (117 mmHg) and low flow velocity at the aortic wall (0.15 m/s(2)) occurred in the region of the PAU. We also found a low value of time-averaged wall shear stress (1.24 N/m(2)) and a high value of the temporal oscillation in the wall shear stress (oscillatory shear index = 0.13) in t…

Malemedicine.medical_treatmentHemodynamicsAorta ThoracicMedicineThoracic aortaHematomamedicine.diagnostic_testEndovascular ProceduresModels CardiovascularSettore ING-IND/34 - Bioingegneria IndustrialeAnatomyTreatment OutcomeAtherosclerosiCardiologyWall shear streCardiology and Cardiovascular MedicineBrief CommunicationsBlood Flow VelocityHumanPulmonary and Respiratory Medicinemedicine.medical_specialtyAortographyAortic RuptureAortic DiseasesAortographyBlood Vessel Prosthesis ImplantationSettore ING-IND/14 - Progettazione Meccanica E Costruzione Di MacchinePenetrating atherosclerotic ulcerPenetrating atherosclerotic ulcerInternal medicinemedicine.arteryFluid-structure interactionShear stressHumansArterial PressureComputer SimulationHemodynamicAortic ruptureUlcerAgedEndovascular Procedurebusiness.industryHemodynamicsStentmedicine.diseaseAtherosclerosisAortic DiseaseBlood pressureRegional Blood FlowSurgeryStress MechanicalbusinessTomography X-Ray Computed
researchProduct

Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.

2012

Autoimmune diseases including multiple sclerosis (MS) are the result of an imbalanced immune tolerance network. Dendritic cells (DCs) are key players in both initiating immunity (immunogenic DCs) and regulating immune responses (tolerogenic DCs = tolDCs) and are potential targets for the treatment of MS. While the immunogenic potential of DCs in fighting infection and cancer has been well established, approaches that exploit their tolerogenic features to promote transplantation tolerance and autoimmunity have emerged only more recently. TolDCs usually maintain antigen-specific T-cell tolerance either directly by inducing anergy, apoptosis, or phenotype skewing or indirectly by induction of …

Malemedicine.medical_treatmentMultiple sclerosisT-LymphocytesImmunologychemical and pharmacologic phenomenaMyelin Basic ProteinImmunotherapyDendritic CellsBiologymedicine.diseasemedicine.disease_causePhenotypeImmunotherapy AdoptiveImmune toleranceAutoimmunityTransplantationImmune systemMultiple Sclerosis Relapsing-RemittingImmunityImmunologymedicineImmunology and AllergyHumansFemaleEuropean journal of immunology
researchProduct

Linking Microstructural Integrity and Motor Cortex Excitability in Multiple Sclerosis

2021

Motor skills are frequently impaired in multiple sclerosis (MS) patients following grey and white matter damage with cortical excitability abnormalities. We applied advanced diffusion imaging with 3T magnetic resonance tomography for neurite orientation dispersion and density imaging (NODDI), as well as diffusion tensor imaging (DTI) in 50 MS patients and 49 age-matched healthy controls to quantify microstructural integrity of the motor system. To assess excitability, we determined resting motor thresholds using non-invasive transcranial magnetic stimulation. As measures of cognitive-motor performance, we conducted neuropsychological assessments including the Nine-Hole Peg Test, Trail Makin…

Malemedicine.medical_treatmentNeuropsychological Testsmultiple sclerosisDisability EvaluationImmunology and AllergyGray MatterMotor skillOriginal ResearchNODDIMotor CortexMiddle AgedTranscranial Magnetic StimulationWhite Mattermedicine.anatomical_structureDiffusion Tensor Imagingtract-based spatial statisticsCardiologyFemalePrimary motor cortexneurite orientation dispersion and density imagingMotor cortexAdultmedicine.medical_specialtymotor thresholdModels NeurologicalImmunologyNeuroimagingGrey matterWhite matterMultiple Sclerosis Relapsing-RemittingInternal medicineMotor systemFractional anisotropyexcitabilitymedicineNeuritesHumansbusiness.industryElectromyographyMultiple sclerosisRC581-607medicine.diseaseEvoked Potentials MotorTranscranial magnetic stimulationImmunologic diseases. AllergybusinessNeurosciencePsychomotor PerformanceDiffusion MRIFrontiers in Immunology
researchProduct